The Venture Codex Logo

The Venture Codex

Overview

Global biopharmaceutical company focused on oncology and specialty care.

Founded

1929

Deals · 12mo

0

Stage focus

Series A
Series B

Geographic focus

United Kingdom
United States

Sector focus

Biotechnology
Pharmaceutical
Product Research

Investment portfolio

9rounds
NAMEDATESIZE
BAKX Therapeutics
Nov 2021Participated
$25 MSeries A
Xilio Therapeutics
Mar 2020Participated
$101 MSeries B
Pyxis Oncology
Jul 2019Participated
$22 MSeries A
Rhythm Pharmaceuticals
Feb 2017Participated
$41 MDebt
Rhythm Pharmaceuticals
Aug 2015Participated
$40 MSeries A
Rhythm Pharmaceuticals
Nov 2012Participated
$8 MSeries B
Rhythm Pharmaceuticals
Jun 2012Participated
$25 MSeries B
Radius Health
Nov 2011Participated
$28 MOther Equity
Syntaxin
Nov 2010Participated
$29 MSeries C
BAKX Therapeutics
Nov 2021Participated
$25 MSeries A
Xilio Therapeutics
Mar 2020Participated
$101 MSeries B
Pyxis Oncology
Jul 2019Participated
$22 MSeries A
Rhythm Pharmaceuticals
Feb 2017Participated
$41 MDebt
Rhythm Pharmaceuticals
Aug 2015Participated
$40 MSeries A
Rhythm Pharmaceuticals
Nov 2012Participated
$8 MSeries B
Rhythm Pharmaceuticals
Jun 2012Participated
$25 MSeries B
Radius Health
Nov 2011Participated
$28 MOther Equity
Syntaxin
Nov 2010Participated
$29 MSeries C
9
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Ipsen: 9 funding rounds are recorded in the selected participation categories.All available history.
Ipsen: 9 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A03
Series B03
Series C+01
Other Equity01
Debt01

Monthly Deal Activity

Ipsen: 9 deals are recorded across 192 months.All available history.
Ipsen: 9 deals are recorded across 192 months. All available history
MonthDeals
Nov '101
Dec '100
Jan '110
Feb '110
Mar '110
Apr '110
May '110
Jun '110
Jul '110
Aug '110
Sep '110
Oct '110
Nov '111
Dec '110
Jan '120
Feb '120
Mar '120
Apr '120
May '120
Jun '121
Jul '120
Aug '120
Sep '120
Oct '120
Nov '121
Dec '120
Jan '130
Feb '130
Mar '130
Apr '130
May '130
Jun '130
Jul '130
Aug '130
Sep '130
Oct '130
Nov '130
Dec '130
Jan '140
Feb '140
Mar '140
Apr '140
May '140
Jun '140
Jul '140
Aug '140
Sep '140
Oct '140
Nov '140
Dec '140
Jan '150
Feb '150
Mar '150
Apr '150
May '150
Jun '150
Jul '150
Aug '151
Sep '150
Oct '150
Nov '150
Dec '150
Jan '160
Feb '160
Mar '160
Apr '160
May '160
Jun '160
Jul '160
Aug '160
Sep '160
Oct '160
Nov '160
Dec '160
Jan '170
Feb '171
Mar '170
Apr '170
May '170
Jun '170
Jul '170
Aug '170
Sep '170
Oct '170
Nov '170
Dec '170
Jan '180
Feb '180
Mar '180
Apr '180
May '180
Jun '180
Jul '180
Aug '180
Sep '180
Oct '180
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '190
May '190
Jun '190
Jul '191
Aug '190
Sep '190
Oct '190
Nov '190
Dec '190
Jan '200
Feb '200
Mar '201
Apr '200
May '200
Jun '200
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '211
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Ipsen: Health & Life Sciences is the largest displayed sector by deal count (9 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Ipsen: Health & Life Sciences is the largest displayed sector by deal count (9 deals). All available history
SectorDeals
Health & Life Sciences9
Consumer & Lifestyle1

Deal Size Distribution

Ipsen: 9 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Ipsen: 9 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M1
$10M-$25M1
$25M-$50M6
$50M-$100M0
$100M-$250M1
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Ipsen: United States has the largest recorded deal count among the displayed regions (8 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Ipsen: United States has the largest recorded deal count among the displayed regions (8 deals). All available history
RegionDeals
United States8
Europe1
Ipsen: 20 co-investors are shown, with MPM Capital sharing 5 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Investment Strategy

Ipsen: Led accounts for 0% and participating for 100% of round participation.All available history.
Ipsen: Led accounts for 0% and participating for 100% of round participation. All available history
CategoryDeals (count)Share (%)
Led00%
Participating9100%
Ipsen: Single-lead accounts for 0% and co-led for 0% of lead dynamics.All available history.
Ipsen: Single-lead accounts for 0% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led00%

Lead dynamics requires at least one led deal in this range

Team

Aurélie Martin

Bioinformatics Engineer

Christophe Jean

Executive Vice President, Strategy and Business Development

Dominique Brard

Executive Vice President, Human Resources

Elisabeth Vey

Analytical Development Leader

Paul Murasko

Head of Digital Customer Interaction for North America

Philippe Lopes-Fernandes

Executive Vice President, Chief Business Officer, Member of the Executive Committee

Sandra Silvestri

EVP, Chief Medical Officer, Head of Global Medical Affairs, Patient Safety & Patient Affairs

Tim Bourque

Associate Director of Warehousing & Logistics